UBS Group’s BiomX PHGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,514
| Closed | -$4.18K | – | 9243 |
|
|
2025
Q1 | $4.18K | Buy |
+7,514
| New | +$4.18K | ﹤0.01% | 7827 |
|
|
2024
Q4 | – | Sell |
-3,785
| Closed | -$3.86K | – | 8945 |
|
|
2024
Q3 | $3.86K | Sell |
3,785
-1,096
| -22% | -$1.12K | ﹤0.01% | 7000 |
|
|
2024
Q2 | $16.4K | Buy |
+4,881
| New | +$16.4K | ﹤0.01% | 6283 |
|
|
2024
Q1 | – | Sell |
-200
| Closed | -$560 | – | 8511 |
|
|
2023
Q4 | $560 | Buy |
200
+190
| +1,900% | +$532 | ﹤0.01% | 7373 |
|
|
2023
Q3 | $37 | Buy |
+10
| New | +$37 | ﹤0.01% | 7903 |
|
|
2023
Q2 | – | Sell |
-300
| Closed | -$916 | – | 8259 |
|
|
2023
Q1 | $916 | Sell |
300
-2,689
| -90% | -$8.21K | ﹤0.01% | 7774 |
|
|
2022
Q4 | $5.68K | Buy |
2,989
+2,615
| +699% | +$4.97K | ﹤0.01% | 7946 |
|
|
2022
Q3 | $1K | Sell |
374
-687
| -65% | -$1.84K | ﹤0.01% | 8898 |
|
|
2022
Q2 | $8K | Buy |
1,061
+916
| +632% | +$6.91K | ﹤0.01% | 7291 |
|
|
2022
Q1 | $3K | Sell |
145
-577
| -80% | -$11.9K | ﹤0.01% | 8411 |
|
|
2021
Q4 | $12K | Buy |
722
+659
| +1,046% | +$11K | ﹤0.01% | 7448 |
|
|
2021
Q3 | $2K | Sell |
63
-1,349
| -96% | -$42.8K | ﹤0.01% | 7821 |
|
|
2021
Q2 | $77K | Buy |
1,412
+1,271
| +901% | +$69.3K | ﹤0.01% | 5027 |
|
|
2021
Q1 | $10K | Buy |
+141
| New | +$10K | ﹤0.01% | 6907 |
|
|
2020
Q4 | – | Sell |
-224
| Closed | -$14K | – | 7550 |
|
|
2020
Q3 | $14K | Buy |
224
+35
| +19% | +$2.19K | ﹤0.01% | 5716 |
|
|
2020
Q2 | $10K | Buy |
+189
| New | +$10K | ﹤0.01% | 6163 |
|